AirSculpt Technologies, Inc. Increase (Decrease) in Accrued Liabilities
AirSculpt Technologies, Inc. (AIRS) reported Increase (Decrease) in Accrued Liabilities of -$1.82 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-10
- AirSculpt Technologies, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was -$1.08M.
- AirSculpt Technologies, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$744.00K.
- AirSculpt Technologies, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $127.00K, a 97.38% decline year-over-year.
- AirSculpt Technologies, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was -$2.71M.
- AirSculpt Technologies, Inc. increase (decrease) in accrued liabilities for fiscal 2025 was -$6.79M, a 173.56% decline from fiscal 2024.
- AirSculpt Technologies, Inc. increase (decrease) in accrued liabilities for fiscal 2024 was $9.22M, a 224.94% increase from fiscal 2023.
- AirSculpt Technologies, Inc. increase (decrease) in accrued liabilities for fiscal 2023 was $2.84M, a 65.26% decline from fiscal 2022.
- AirSculpt Technologies, Inc. increase (decrease) in accrued liabilities for fiscal 2022 was $8.17M, a 71.37% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$1.82M 10-Q · filed 2026-08-10 | -$1.70M derived: sum of 3 quarters · filed 2026-08-10 | -$4.40M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2026-03-31 | -$744.00K 10-Q · filed 2026-05-08 | -$617.00K derived: sum of 2 quarters · filed 2026-05-08 | -$3.32M derived: sum of 3 quarters · filed 2026-05-08 | -$5.32M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-12-31 | $127.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-06 | -$2.58M derived: sum of 2 quarters · filed 2026-04-06 | -$4.57M derived: sum of 3 quarters · filed 2026-08-10 | -$6.79M 10-K/A · filed 2026-04-06 | |
| 2025-09-30 | -$2.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$4.70M derived: sum of 2 quarters · filed 2026-08-10 | -$6.91M 10-Q · filed 2025-11-07 | -$2.06M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-06-30 | -$1.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$4.21M 10-Q · filed 2026-08-10 | $648.00K derived: sum of 3 quarters · filed 2026-08-10 | -$1.49M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-03-31 | -$2.21M 10-Q · filed 2026-05-08 | $2.64M derived: sum of 2 quarters · filed 2026-05-08 | $502.00K derived: sum of 3 quarters · filed 2026-05-08 | $7.53M derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | $4.86M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-06 | $2.72M derived: sum of 2 quarters · filed 2026-04-06 | $9.74M derived: sum of 3 quarters · filed 2026-04-06 | $9.22M 10-K/A · filed 2026-04-06 | $7.59M 10-K · filed 2025-03-14 |
| 2024-09-30 | -$2.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $4.89M derived: sum of 2 quarters · filed 2025-11-07 | $4.37M 10-Q · filed 2025-11-07 | $5.17M derived: sum of 4 quarters · filed 2026-04-06 | |
| 2024-06-30 | $7.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $6.51M 10-Q · filed 2025-08-01 | $7.31M derived: sum of 3 quarters · filed 2026-04-06 | $5.50M derived: sum of 4 quarters · filed 2026-04-06 | |
| 2024-03-31 | -$519.00K 10-Q · filed 2025-05-02 | $279.00K derived: sum of 2 quarters · filed 2026-04-06 | -$1.52M derived: sum of 3 quarters · filed 2026-04-06 | -$429.00K derived: sum of 4 quarters · filed 2026-04-06 | |
| 2023-12-31 | $798.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-04-06 | -$1.00M derived: sum of 2 quarters · filed 2026-04-06 | $90.00K derived: sum of 3 quarters · filed 2026-04-06 | $2.84M 10-K/A · filed 2026-04-06 | $2.18M 10-K · filed 2024-02-27 |
| 2023-09-30 | -$1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$708.00K derived: sum of 2 quarters · filed 2024-11-08 | $2.04M 10-Q · filed 2024-11-08 | $6.68M derived: sum of 4 quarters · filed 2025-03-14 | |
| 2023-06-30 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $3.84M 10-Q · filed 2024-08-09 | $8.48M derived: sum of 3 quarters · filed 2025-03-14 | $10.16M derived: sum of 4 quarters · filed 2025-03-14 | |
| 2023-03-31 | $2.75M 10-Q · filed 2024-05-10 | $7.39M derived: sum of 2 quarters · filed 2025-03-14 | $9.07M derived: sum of 3 quarters · filed 2025-03-14 | $10.47M derived: sum of 4 quarters · filed 2025-03-14 | |
| 2022-12-31 | $4.64M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $6.32M derived: sum of 2 quarters · filed 2025-03-14 | $7.72M derived: sum of 3 quarters · filed 2025-03-14 | $8.17M 10-K · filed 2025-03-14 | |
| 2022-09-30 | $1.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $3.09M derived: sum of 2 quarters · filed 2023-11-13 | $3.53M 10-Q · filed 2023-11-13 | $5.87M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-06-30 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $1.85M 10-Q · filed 2023-08-11 | $4.18M derived: sum of 3 quarters · filed 2024-02-27 | $6.73M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-03-31 | $446.00K 10-Q · filed 2023-05-12 | $2.78M derived: sum of 2 quarters · filed 2024-02-27 | $5.33M derived: sum of 3 quarters · filed 2024-02-27 | $5.67M derived: sum of 4 quarters · filed 2024-02-27 | |
| 2021-12-31 | $2.34M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $4.88M derived: sum of 2 quarters · filed 2024-02-27 | $5.23M derived: sum of 3 quarters · filed 2024-02-27 | $4.77M 10-K · filed 2024-02-27 | |
| 2021-09-30 | $2.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $2.89M derived: sum of 2 quarters · filed 2022-11-14 | $2.43M 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | $346.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$114.00K 10-Q · filed 2022-08-12 | |||
| 2021-03-31 | -$460.00K 10-Q · filed 2022-05-13 | ||||
| 2020-12-31 | $1.11M 10-K · filed 2023-03-10 | ||||
| 2019-12-31 | $392.00K 10-K · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |